Pharm Exec Podcast InterviewsThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

• Contents
• Discussions

Pages: 1  2  

EMERGING LEADERS: Elizabeth MutisyaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Elizabeth Mutisya, VP, US Medical Affairs, CMO, Solvay Pharmaceuticals (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - November 11, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Bill Trombetta 2009 Industry Audit (Part 5)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
n this final episode, Trombetta reviews the business strategy of the survey runner up, Genentech and how the integration with Roche may impact the success of this perennial favorite in the survey. We end with a fairly optimistic view that big pharma is far from down on the count its cash hoard and considerable human assets will continue to help it move forward agains the competitive threat of smaller, nimble and more focused stealth pharmas. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - November 5, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Bill Trombetta 2009 Industry Audit (Part 4)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Professor Trombetta tackles the question of whether size and scale matter as a predictor of shareholder value his answer is management drives results, regardless of the company being big or small. He also profiles the attributes that made Gilead Sciences the winner of this year’s poll, and how Biogen/Idec slipped from first to third place. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - November 4, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Bill Trombetta 2009 Industry Audit (Part 3)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Good management is a mainstay for success regardless of whether a company is big or small. In this episode, Trombetta describes his metrics-driven approach to evaluating internal management strategies and highlights best practices from individual companies. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - November 3, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Bill Trombetta 2009 Industry Audit (Part 2)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Professor Trombetta gives a frank assessment of factors that are transforming the commercial and policy environment in the biopharm sector. Will the industry remain resilient in the wake of the worst global recession of the post-war era? (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - November 2, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Bill Trombetta 2009 Industry Audit (Part 1)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Bill Trombetta explains changes in key evaluation metrics for this year’s survey as well as the implications of adding 11 new companies to the list, making it reflective of the emergence of generics, biotech and specialty firms as key competitors to traditional big pharma. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - November 1, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

EMERGING LEADERS: Kathryn MetcalfeEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Kathryn Metcalfe, VP, Corporate Reputation and Policy Communications, Pfizer (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 24, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

EMERGING LEADERS: Michelle DippEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Michelle Dipp, VP & Head of US Center of Excellence for External Drug Discovery, GlaxoSmithKline (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 23, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

EMERGING LEADERS: Paulash MohsenEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Paulash Mohsen, Vice President, Primary Care Strategy, Pfizer (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 22, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

EMERGING LEADERS: Jennifer SmithEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Jennifer Smith, Executive Director, Medical Education, Wyeth (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 21, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

EMERGING LEADERS: Joe SheildsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Joe Shields, Product Director, Enbrel (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 20, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

EMERGING LEADERS: Scott CormackEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Scott Cormack, President and CEO, OncoGenex Pharmaceuticals (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 19, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

EMERGING LEADERS: Frank KarbeEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Frank Karbe, Chief Financial Officer, Exelixis (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 18, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

EMERGING LEADERS: Virginia CarnahanEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Virginia Carnahan, Vice President, New Product Planning and Strategy, Vertex Pharmaceuticals (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 17, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

EMERGING LEADERS: Luca SantarelliEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Luca Santarelli, Global Head of Clinical Research and Exploratory Development in CNS, Roche (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 16, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

TFC: Trends in Patient AccessEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Pharmaceutical Executive Editor-in-Chief Bill Looney visits with Bob Mauch, president of Xcenda, to discuss: How health reform might affect quality of care and what preparations are being made by stakeholders like manufacturers and payers. Immediate and potential long-term impact of biosimilars in the specialty space. Use of patient adherence and patient assistance programs as a way to promote proper therapy utilization. The current and future state of hot button issues like comparative effectiveness and REMS. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 16, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

EMERGING LEADERS: Carrolee BarlowEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Carrolee Barlow, Chief Scientific Officer, BrainCells (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 15, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

TFC: The Future of OncologyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
With the U.S. healthcare system at an unprecedented crossroads, cancer care has emerged as one of the most hotly debated subjects. Stakeholders include manufacturers, physicians, patients, payers and service providers even the government itself. And all have their own set of concerns to be addressed. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - August 24, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

WOTY: Deborah Dunsire of Millennium PharmaceuticalsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Deborah Dunsire of Millennium Pharmaceuticals shares the path she took to an incredible career. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - August 11, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

WOTY: Lynn Gaudioso of Ivanhoe StrategiesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Lynn Gaudioso of Ivanhoe Strategies talks about her career. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - April 11, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

WOTY: Kathy Giusti of MMRF and MMRCEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Kathy Giusti of MMRF and MMRC discusses her career. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - April 1, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

WOTY: Tamar Howsen of JSB PartnersEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Tamar Howsen of JSB Partners talks about her career. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - April 1, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

WOTY: Catherine Sibley of ShireEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Maureen Regan of Regan Campbell Ward McCann reflects on her career. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - April 1, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

WOTY: Maureen Regan of Regan Campbell Ward McCannEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Maureen Regan of Regan Campbell Ward McCann reflects on her career. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - April 1, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

WOTY: Sarah Harrison of H&S EnterpriseEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Sarah Harrison of H&S Enterprise talks about the steps she took to launch a successful career. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - April 1, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

WOTY: Lynn O'Connor Vos of Grey Healthcare GroupEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Lynn O'Connor Vos of Grey Healthcare Group discusses her career. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - April 1, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

WOTY: Meryl Zausner of NovartisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Meryl Zausner of Novartis Oncology reflects on her career. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - April 1, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

TFC: Changing Relationship between Manufacturers and Managed CareEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Pharmaceutical Executive Editor Pat Clinton discusses How the relationship between Pharmaceutical Manufacturers and Managed Care has Changed with Ken Trader, VP of Strategic Accounts for Managed Care for ABSG. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - March 15, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

TFC: Patient Adherence ProgramsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Pharmaceutical Executive Editor Pat Clinton discusses Patient Adherence Programs with Jan Nielsen, VP of Clinical Services for ICS. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - March 14, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

WOTY: Ahnal Purohit of Purohit NavigationEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Ahnal Purohit of Purohit Navigation reflects on her career move from professor to president and how she translated her analytical skills to better brands. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - March 13, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

WOTY: Catherine Sohn of GlaxoSmithKlineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
GlaxoSmithKline’s Catherine Sohn talks about the strength her father gave her to pursue her dreams and why it makes her want to give back. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - March 13, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

WOTY: Carolyn Glynn of RocheEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Carolyn Glynn of Roche talks about representing her company and the challenges faced when championing outside constituents inside the company to give them a voice. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - March 13, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

WOTY: HBA’s CEO Laurie Cooke and HBA President Ceci ZakEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Woman of the Year Podcast: HBA’s CEO Laurie Cooke teams up with HBA President Ceci Zak to share how the Woman of the Year Award has changed the face of industry. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - March 13, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

TFC: The potential impact of REMSEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Pharmaceutical Executive Editor Joanna Breitstein discusses the potential impact of REMS with Jay Jackson. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - March 13, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

TFC: Is REMS the end of the world as we know it?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Pharmaceutical Executive Editor Joanna Breitstein sits down with Peyton Howell, president of consulting services and health policy for AmerisourceBergen Specialty Group, to examine key operational and clinical considerations of successful REMS programs. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - February 25, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Bill Trombetta Industry Audit (Part 5)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Biogen Idec: This was Biogen's year, says Professor Bill Trombetta. In this episode, Bill spotlights some of the company's achievements, including an all-star performance at simultaneously managing assets and margins, then explores some ways in which companies need to re-envision their roles to be successful in tomorrow's market. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - December 15, 2008 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Bill Trombetta Industry Audit (Part 4)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Genentech: Another permanent resident on the Top Four list, Genentech turns in mind-bending numbers. The big question: can Genentech keep it up. Bill Trombetta looks at the original biotech's remarkable successes and its challenges. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - December 15, 2008 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Bill Trombetta Industry Audit (Part 3)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Johnson & Johnson: A perennial member of the Top Four, J&J defies the conventional wisdom; it's a big company that still manages to grow, a sprawling, diversified company that still has focus. And along with just three other companies on our list, it created shareholder value in 2007. Bill Trombetta explains how. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - December 15, 2008 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Bill Trombetta Industry Audit (Part 2)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Eli Lilly: With double-digit growth in sales, and a solid improvement in revenue per employee, Lilly placed fourth in the Company of the Year rundown. Bill Trombetta explains Lilly's position as a big/small pharma and maps out the challenges that lie ahead for Lilly. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - December 15, 2008 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Bill Trombetta Industry Audit (Part 1)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
How to measure a pharma company If you want to want to truly understand how well a company is performing, you need to get past the basics of revenue, profit margin, and price earnings ratio. In this episode, Bill Trombetta explains which metrics really get at the heart of good pharma management. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - December 15, 2008 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Tariq Arshad, MD of PfizerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Want to know how to market in today’s resource-constrained environment? Tariq Arshad, MD, senior manager of worldwide commercial development for Pfizer, said that starting his career in Pakistan taught him everything he needed to know. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 15, 2008 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Michael Burke of Ovation PharmaceuticalsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Michael Burke, chief commercial officer for Ovation Pharmaceuticals, talks about the difference leadership makes in the specialty space. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 15, 2008 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Barry Greene of AlnylamEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Barry Greene, President and COO of the RNAi powerhouse Alnylam, traces his rise to the top through mentors and medicine. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 15, 2008 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Martin Jernigan of NovoEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Martin Jernigan, associate vice president of Novo Nordisk’s liraglutides launch, talks about how to merge science and commercialization on an organizational level. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 15, 2008 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Sean McLoughlin of GlaxoSmithKlineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Leadership is about making courageous and clear decisions, says Sean McLoughlin, product director of GlaxoSmithKline’s diabetes franchise, which can be different for pharma’s growing number of customers. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 15, 2008 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Adnan Mjalli of TransTech PharmaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Innovation hasn’t survived in Big Pharma, says Adnan Mjalli, founder, president, and CEO of TransTech Pharma. But bringing science back into the C-suite could help. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 15, 2008 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Angela Moskow of Sanofi-AventisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Angela Moskow, vice president of diabetes marketing for Sanofi-Aventis, reflects on her career-long focus on diabetes, and offers some leadership tips she’s picked up along the way. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 15, 2008 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Wendy Niebler, DO of Shire PharmaceuticalsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
How does a physician come to join the pharma industry? There’s no roadmap, says Wendy Niebler, DO, vice president of global medical affairs of ADHD for Shire Pharmaceuticals, but you can still make an impact on patients. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 15, 2008 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Rich Tillyer of MerckEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
If companies are going to create best-in-class drugs, that work needs to start early in development, says Rich Tillyer, senior vice president, worldwide preclinical development for Merck. In this podcast, Tillyer traces his career at Merck and talks about the importance of providing scientists with the space to innovate. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 15, 2008 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

Hoji Alimi of OclulusEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Life didn’t start easy for Hoji Alimi, Founder, President, and CEO of Oculus Innovative Sciences, who was exhiled from Iran as a teenager. But conviction in a compound which some have even called miracle water pointed the path toward success. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - October 15, 2008 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts